chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she experienced a fever; muscle aches; nausea; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (she experienced a fever), MYALGIA (muscle aches), NAUSEA (nausea) and ARTHRALGIA (joint pain) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in February 2021.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced PYREXIA (she experienced a fever), MYALGIA (muscle aches), NAUSEA (nausea) and ARTHRALGIA (joint pain). At the time of the report, PYREXIA (she experienced a fever), MYALGIA (muscle aches), NAUSEA (nausea) and ARTHRALGIA (joint pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported No treatment medication was reported
This spontaneous report as received from a registered nurse refers to a patient of unknown age. The reporter stated that the patient received an expired dose of PNEUMOVAX 23m batch # HJ006082 (which corresponds to lot # 0744AE) with expiry date 12-APR-2014. Dosing information and route of administration were not provided. No adverse symptoms were reported. Additional information has been requested.
1st dose pfizer vaccine was given to patient on 07/09/2021. We found out on 07/09/2021 vaccine was stored outside the recommended 31 day expiration window.
patient states that there was a little arm soreness the day after injection and then it went away. he states that while taking a shower today 1/18/2023 he noticed his arm was very sore in the location of the injection.  i advised him to call and check in with his doctor.
Normal stuff that everyone else had; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Normal stuff that everyone else had) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 immunisation.     Concurrent medical conditions included Allergy to vaccine (flu vaccine).    On 13-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Normal stuff that everyone else had). At the time of the report, VACCINATION COMPLICATION (Normal stuff that everyone else had) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2022-453811 (Patient Link).
Vaccine was administered outside the BUD. NO adverse reaction reported by patient. Manufacturer supports exclusion. No re-administration is requried.
Discharge Provider:  MD Primary Care Provider : None Physician, DO None   Admission Date: 8/28/2022 Admitting Diagnoses:  Pneumonia due to COVID 19 virus   Discharge Date: 9/2/2022  PRESENTING PROBLEM: Pneumonia due to COVID-19 virus   HOSPITAL COURSE: Patient is a 74-year-old female with past medical history significant for cerebral palsy, dysphagia, hyperlipidemia, depression and anxiety.  Patient had tested positive for COVID as an outpatient on 08/25 and due to worsening shortness of breath and hypoxia presented to the emergency department.  She was admitted on 2 L of supplemental oxygen.  She was started on remdesivir and given a dose of Lasix at admission.   Patient had been on a dysphagia diet at the facility.  She was re-evaluated by SLP during admission who recommended video swallow study which showed no concerns and diet was upgraded to general solids and thin liquids.   She completed Remdezivir. Dexamethasone was added when O2 on pulse ox dropped below 90%. She was evaluated by pulm rehab and O2 was arranged for use at her discharge facility. She was stable for discharge back to fountain view AL facility.  She will be discharged with a prescription for dexamethasone to complete a 10 day course.  She will be out of isolation after 10 days from her positive test on 08/25.  The patient can continue supportive care measurements after discharge including over-the-counter antitussive medications, and she was also prescribed an albuterol inhaler.   At time of discharge the patient was hemodynamically stable and all questions were answered at bedside.
All symptoms reported here are following dose 2 on 3/10/21:  Headache, fatigue beginning on 3/12/21 and still present Onset of tingling to mouth, lip and tongue noted late afternoon on 3/16/21 Loss of taste onset 3/16/21 Facial drooping noted late 3/16/21 Increased facial drooping, numbnes, tingling left side of face and inability to close left eye on 3/17/21
Flu vaccine and Tdap vaccine administered RN and Nursing Student. Within 30 seconds the pt stated that she was feeling dizzy and that her legs were feeling tingly. I helped the pt to elevate her legs and reclined her head slightly. on the exam chair. Pt leaned forward with eyes closed. Pt was slumped over and had some loss of color in the face and lips. I helped the pt to sit up while saying her name. No response from pt. Pt began to make grunting sounds, and her body appeared to be jerking. I was beside the pt to prevent her from falling. The pt appeared to be sweating. Her shirt was wet on the front and back. I heard flatulation sounds. This lasted for approximately 2 minutes. RN called for help. Two other RNs came to the room. Nurse was saying the pt's naame, and another nurse was holding an alcohol pad to the pt's nose. The pt's head was reclined slightly. I left the room to get the crash cart, and I notified, FNP about the situation. I arrived back to the pt's room with the crash cart, and FNP assessed the pt. At this time, the pt was alert and oriented. The other jerking  and grunting had subsided. She was laying on her side holding an emesis bag. Pt stated that she was feeling nauseated. RN got the vials machine and checked the pt's vital signs starting at approximately 0920. The pt's BP was 97/65 ans trending up to 135/63 after 3 checks per RN. She instructed me to check again in 5 minutes. The pt stated that she was feeling better. I checked her VS again. Her BP had dropped to 78/52, and she stated that she was feeling hot, nauseated, and dizzy. I held an ice pack covered with a towel on her forehead. She stated that she did not eat anything today. She was given an orange juice and peanut butter crackers. She drank a few sips of juice, and she ate 2 crackers. The vital signs were checked every 5-10 minutes until approximately 1005. BP was trending up. Pt denied feeling dizzy, sweaty, nauseated, and hot. When asked how she felt, she stated that she felt good at this time. Pt stated that she did not need an ambulance to be called. Pt stood up slowly and walked. She stated that she was still feeling well, and that she did not have any concerns or abnormal symptoms. I encouraged the pt to notify her PCP of this occurrence.
parents state pt became ill around 1145PM arm sl swollen & pink 1230PM, t101 230AM, t104.1, chills, wet bed; 4AM, t99.1; APAP given for fever; 10AM feeling better; t nl; pt not seen by MD;
Itching and redness at injection site spreading out about 2 inches began 7 days post injection
as per my PCP, tendinitis in left upper arm due to the vaccine. Currently undergoing anti-inflammatory naproxen for two weeks and will see how it is after.
First dose given 05/19/21. Second dose given 06/10/21, 22 day interval.
Heart palpiations, increased blood pressure, drop in blood pressure. Diagnosed with POTS which was later reversed. Also diagnosed with Livedo Reticularis.
she's ever been allergic to this; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: The reporter is the patient.  A female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "she's ever been allergic to this".  Additional information: Patient was trying to schedule an appointment online and she got into the fact sheet and in the bottom it asked to scan to capture. Reporter said they wanted patient to answer some questions that she is ever been allergic to this. Patient chose the Pfizer drug and the website was asking her to scan a QR code and she didnt know that.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
60 y.o.       Admit Date:  8/31/2022     Discharge Date: 9/2/22     Principal Dx/ Final Dx:  Hypotension due to drugs     Relevant Inpt Dx:  Principal Problem:    Hypotension due to drugs  Active Problems:    COVID    AKI (acute kidney injury)    Essential hypertension    PAD (peripheral artery disease)           HPI:     Hospital Course:    This 60 year old man was admitted with hypotension and AKI.  He was given ivf and multiple BP meds were held.  He is improved today.  AKI has resolved.  Creatinine was 2.1 on admission and is 1.1 today.  He will resume his coreg.  His nifedipine and zestoretic are still held.  He will follow up with pcp in a week and re assess BP.  I have also held mobic due to aki and covid.       He did test positive for covid and did receive steroids and remdesivir.  He is not hypoxic, CXR ok, and lungs are clear so would not give further treatment              @HOSPDCED@     Consults:    IP CONSULT TO SOCIAL WORK           Disposition:  home     Discharge Condition:  fair
Upon waking the morning of 3/24/2021, client experienced confusionMRI did show punctate acute/subacute infarct identified within the pons in the cortex of the left temporal/left parietal lobe. She was also noted to have stable moderate chronic ischemic microvascular changes and a stable old lacunar infarct, as well as a 8 x 6 x 6 mm meningioma arising from the right lateral anterior falx.
Narrative: COVID infection following COVID vaccine series 04/21, Pfizer, dose #1 05/17, Pfizer, dose #2 08/10 COVID swab, result: detected 08/11 pt admit to ED dx: covid + and detox 08/11 CXR impression: Increased right lateral basilar opacity. Correlate clinically for pneumonia including viral/atypical etiology and follow-up to resolution.
Immediately upon receiving varivax SQ in right arm, greater than usual redness, noted at injection site. Kept for observation x 10 minutes. 5mmx10mm induration and 20mm surrounding redness. Benadryl 1/2 tsp given per MD verbal order. Checked by MD (+) wheal and flare reaction. Advised to go straight to ER if respiratory difficult develops.
The individual was given a .25ml dose instead of the necessary .5ml dose.  Patient was contacted to return for another shot of the .5ml dose 8 weeks from the date of the most recent vaccination.
very large localized reaction approx 15 x 17 cm fever, chills, nausea and vomiting
headache; muscle aches; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 29 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administration date 2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (product-COVID 19, administration time:02:00 PM, administrator route:Intramuscular, vaccine location:Left arm, dose number:1), administration date: 17Mar2021, when the patient was 29 years old, for Covid-19 immunization, reaction(s): "left arm very tender". The following information was reported: HEADACHE (non-serious) with onset 08Apr2021 12:00, outcome "recovered", described as "headache"; MYALGIA (non-serious) with onset 08Apr2021 12:00, outcome "recovered", described as "muscle aches". Therapeutic measures were not taken as a result of headache, myalgia.  Additional information: The patient was not tested for positive for covid, since after or before vaccination.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sinusitis; Tested COVID positive Nov 6 2020; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Sinusitis), COVID-19 (Tested COVID positive Nov 6 2020), PYREXIA (Fever) and CHILLS (Chills) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Positive) on 06-Nov-2020.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021, the patient experienced SINUSITIS (Sinusitis), COVID-19 (Tested COVID positive Nov 6 2020), PYREXIA (Fever) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK, bid. On 12-Jan-2021, SINUSITIS (Sinusitis), PYREXIA (Fever) and CHILLS (Chills) had resolved. At the time of the report, COVID-19 (Tested COVID positive Nov 6 2020) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Nov-2020, SARS-CoV-2 test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product use was reported. Patient did not consult HCP.
Developed diffuse rash which has persisted, recent biopsy shows Granuloma Annularum
got period; injection site very hot to the touch; arm very sore at injection site; gland/lymph node in arm pit of injected arm was swollen and sore; gland/lymph node in arm pit of injected arm was swollen and sore; sweating profusely; freezing but clammy; freezing but clammy; Feeling run down; headache; nauseous; body stiffness, neck stiff; chest ache; blah feeling; menthol taste/feeling again but fine otherwise; This is a spontaneous report from a contactable consumer (patient). This consumer reported that a 36-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0153), via an unspecified route, administered in arm right on 12Apr2021 at 05:30 PM (age at vaccination was 36 year) as dose 2, single for covid-19 immunization. Medical history included asthma from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient was not pregnant at the time of vaccination. No other vaccines were recieved within 4 weeks prior to covid-19 vaccine. The patient previously took dilaudid and experienced allergy and bnt162b2 (Batch/Lot Number was not reported), via an unspecified route, administered in arm right on 19Mar2021 at 08:15 AM (age at vaccination was 36 year) as dose 1, single for covid-19 immunization and experienced menthol taste/feeling in mouth/throat, had to start supplementing formula bc milk production dropped drastically. On 12Apr2021, the patient experienced feeling of menthol taste but was fine otherwise. On 13Apr2021, freezing but clammy, freezing but clammy, feeling run down, headache, nauseous, body stiffness, neck stiff, chest ache, sweating profusely and blah feeling. On 14Apr2021, arm very sore at injection site, gland/lymph node in arm pit of injected arm was swollen and sore and injection site very hot to the touch. On 28Apr2021, got period. On 13Apr2021, the menthol feeling had gone when the patient woke up. At around 01:15 she started feeling run down, freezing but clammy, headache, nauseous, body stiffness (like the patient was in a bad accident), chest ache. The patient felt asleep around 3, woke up around 5:30 sweating profusely but feeling mostly normal just a headache, blah feeling and stiff neck. On 14Apr2021, the patient woke up at 5:30 freezing again, arm was very sore at injection site and gland/lymph node in arm pit of injected arm was swollen and sore. 5:40 pm noticed injection site very hot to the touch. On 15Apr2021, the patient woke up feeling totally normal, injection site not hot at all, arm was still a little sore where injection was and arm pit was still sore. On 28Apr2021, the patient got her period even though she was nursing which she have never had. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. The outcome of the event injection site very hot to the touch was recovered on 15Apr2021; menthol taste/feeling again but fine otherwise was recovered on 13Apr2021; while outcome of all other events was recovering.  No follow-up attempts are needed. No further information is expected.
large red knot as big or bigger than a fifty cents piece; fever of 101.8;
Thursday morning (6-21-18) patient reports severe vomiting, fever (unknown max) and delirium/confusion that persisted until Saturday 6-23-18. Pt denies any rashes, redness or soreness at injection site. Pt states "she was too sick to go to the ER".
Early vaccine administration, 2nd dose Shingrix Vaccine administered on the 32nd day.
shortness of breath; Lightheadedness; fatigue; confusion; usually hypoglycemic but this time around his blood work showed a little lower sugar then usual.; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), DIZZINESS (Lightheadedness), FATIGUE (fatigue), CONFUSIONAL STATE (confusion) and BLOOD GLUCOSE DECREASED (usually hypoglycemic but this time around his blood work showed a little lower sugar then usual.) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypoglycemia, Sleep apnea, Sjogren's and Interstitial lung disease.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced DYSPNOEA (shortness of breath), DIZZINESS (Lightheadedness), FATIGUE (fatigue), CONFUSIONAL STATE (confusion) and BLOOD GLUCOSE DECREASED (usually hypoglycemic but this time around his blood work showed a little lower sugar then usual.). At the time of the report, DYSPNOEA (shortness of breath), DIZZINESS (Lightheadedness), FATIGUE (fatigue), CONFUSIONAL STATE (confusion) and BLOOD GLUCOSE DECREASED (usually hypoglycemic but this time around his blood work showed a little lower sugar then usual.) outcome was unknown.
Since receiving the vaccine, I have developed joint  pain in my fingers, knees, and ankles.  In the beginning it hurt bad to the point of waking my up at night.  It has lessened some, but it still hurts.  I have trouble standing up from sitting (with my knees) and in the morning my ankles hurt and I cannot walk normally.  As the day goes on, it loosens up.  This has been ongoing and has not gone away (now 5 months post vaccine).  I was told the vaccine can cause inflammation.  I did NOT have this joint pain previously.
weird taste; Lightheaded; A funny taste in my mouth; This is a spontaneous report from a contactable consumer (patient).  A 47-years-old non pregnant female patient received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number: not reported) administered in left arm via an unknown route of administration, on 04Mar2021 at 12:30pm as single dose for covid-19 immunization. Medical history included multiple sclerosis, complex regional pain syndrome, fibromyalgia, hypertension, hypothyroidism, hypokalaemic syndrome, intervertebral disc degeneration, vitamin d deficiency, hypersensitivity. On 04Mar2021 at 13:30pm, the patient was lightheaded for about 4 hours, a funny taste in mouth started about 30 minutes after the vaccine and lasted a few hours but food still has a weird taste the next day. No treatment was received for the events. The outcome of the events was recovered with sequelae. It was reported that patient received no other vaccine in four weeks. In two weeks, patient received other unspecified vaccine first dose on left arm on o4Mar2021. The patient was not diagnosed with covid prior vaccination and not tested for covid post vaccination. The patient had known allergies. No follow up attempts were possible, information about lot/batch number cannot be obtained.
Sudden extreme feeling of burning up, nausea, profuse sweating and shakiness, followed by the feeling of almost fainting upon waking up at 8am. Severe migraine followed, which remained present for the entire day, regardless of pain medication being taken. Severe fatigue and body aches remained all day as well.
Within two weeks of vaccination: energy level down, muscle ache, diarrhea, congestion, extra gas (intestinal).  Ongoing: extra gas (intestinal); cold flashes that course quickly through body; tingling in arms, hands (like a buzz or very fine pins and needles); irritability; itchiness (upper body, face and head); numbness on front of tongue; stiff finger joints; brain fog; quick onset of fatigue; sudden faint feeling; feeling of weakness in muscles; bruise on right upper arm which remained for a couple weeks; apparent reduced allergen/pollen resistance.  Also, it seems I may now be having novel allergic reactions to peanuts. I had long consumed peanuts and peanut butter without incident before taking the vaccine.
318 patients received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date). On 17-Aug-2021, EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter did not allow further contact
This spontaneous report was received from a registered nurse regarding a 4 month old male patient. The patient's medical history included eczema. The patient's concurrent conditions and concomitant medications were not provided. On 09-FEB-2018, the patient was vaccinated with ROTATEQ oral liquid, orally, lot # N005626 with expiration date 26-NOV-2018, for routine vaccinations (anatomical location was not provided). Also, on the same day, the patient was vaccinated with PREVNAR, lot # S43842 with expiration date 31-OCT-2018, and PENTACEL, lot #C5418AA with expiration date 2-SEP-2018 (strength, dose, frequency, route and indication were not provided). On an unspecified date in February 2018, reported as within 48 hours after vaccination, the patient experienced a "horrible exacerbation of eczema". Treatment was given for the event but the patient did not seek medical attention. At the reporting time, the outcome of eczema was reported as resolving. Laboratory studies were not performed. The reporter did not assess the relatedness between ROTATEQ and the aforementioned event.
Later that night patient had several episodes of dizziness, syncope resulting in a concussion, and a seizure.